Deerfield Management Adjusts BiomX Inc. Stake

TL;DR

Deerfield updated their BiomX filing, likely adjusting their significant stake.

AI Summary

Deerfield Management Company, L.P. and its affiliates, including Deerfield Healthcare Innovations Fund II, L.P., have amended their Schedule 13D filing for BiomX Inc. as of May 30, 2024. The filing indicates a change in beneficial ownership, though specific new holdings or changes in percentage are not detailed in this excerpt. The group previously held a significant stake and this amendment likely reflects ongoing management or adjustments to their investment strategy in BiomX Inc.

Why It Matters

This filing signals potential shifts in major shareholder positions, which can influence BiomX's strategic direction and stock performance.

Risk Assessment

Risk Level: medium — Changes in holdings by major institutional investors can indicate shifts in confidence or strategy, impacting the stock.

Key Players & Entities

• Deerfield Management Company, L.P. (company) — Filing entity and investment manager
• BiomX Inc. (company) — Subject company
• Deerfield Healthcare Innovations Fund II, L.P. (company) — Affiliated entity of Deerfield Management
• David Clark (person) — Associated with Deerfield Management Company, L.P.

FAQ

Key Financial Figures

• $0.0001 — ame of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• e663672_sc13da-biomx.htm (SC 13D/A) — 120KB
• 0001193805-24-000728.txt ( ) — 121KB

Interest

Item 5. Interest in Securities of the Issuer. Items 5(a), (b) and (c) of the Schedule 13D hereby amended and restated in their entirety as follows: (1) Deerfield Mgmt V, L.P. Number of shares: 3,055,049 (comprised of shares held by Deerfield Private Design Fund V, L.P.) Percentage of Shares: 4.38 %* (2) Deerfield Private Design Fund V, L.P. Number of shares: 3,055,049 Percentage of Shares: 4.38 %* (3) Deerfield Mgmt HIF II, L.P., L.P. Number of shares: 3,055,049 (comprised of shares held by Deerfield Healthcare Innovations Fund II, L.P.) Percentage of Shares: 4.38 %* (4) Deerfield Healthcare Innovations Fund II, L.P. Number of shares: 3,055,049 Percentage of Shares: 4.38 %* (5) Deerfield Management Number of shares: 6,110,098 (comprised of shares held by Deerfield Private Design Fund V, L.P. and Deerfield Healthcare Innovations Fund II, L.P.) Percentage of Shares: 8.75 %* (6) Flynn Number of shares: 6,110,098 (comprised of shares held by Deerfield Private Design Fund V, L.P. and Deerfield Healthcare Innovations Fund II, L.P.) Percentage of Shares: 8.75 %* *Throughout this report, the percentage of outstanding shares of Common Stock beneficially owned by the Reporting Persons reflects 69,806,440 shares of Common Stock outstanding as of May 23, 2024, as set forth in the Company’s preliminary proxy statement filed with the Securities and Exchange Commission on May 28, 2024. (b) (1) Deerfield Mgmt V, L.P. Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 3,055,049 Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 3,055,049 CUSIP No. 09090D103 9 of 10 Pages (2) Deerfield Private Design Fund V, L.P. Sole power to vote or direct the vote: 0 Shared power to vote or direct the vote: 3,055,049 Sole power to dispose or to direct the disposition: 0 Shared power to dispose or direct the disposition: 3,055,049 (3) Deerfield Mgmt HIF II, L.P. S

View Full Filing

View this SC 13D/A filing on SEC EDGAR